Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.12%393.26B | -4.45%388.91B | -3.69%93.75B | -1.77%103.99B | -6.10%96.41B | -6.30%94.75B | 8.22%407.02B | 1.01%97.35B | 3.86%105.87B | 12.19%102.68B |
| Cost of revenue | 1.00%345.8B | -4.69%342.37B | -5.67%82.23B | -1.61%91.77B | -5.97%84.72B | -5.66%83.66B | 9.29%359.21B | 3.47%87.16B | 5.00%93.27B | 13.13%90.1B |
| Gross profit | 1.97%47.46B | -2.67%46.54B | 13.17%11.53B | -2.97%12.23B | -7.05%11.69B | -10.89%11.09B | 0.78%47.81B | -16.11%10.19B | -3.85%12.6B | 5.92%12.58B |
| Operating expense | 3.70%40.1B | 1.52%38.67B | -5.43%10.21B | 7.17%9.81B | 2.23%9.26B | 3.38%9.39B | 8.93%38.09B | 10.38%10.8B | 5.08%9.15B | 10.73%9.06B |
| Staff costs | ---- | ---- | ---- | 1.99%4.52B | 3.54%4.27B | 6.50%4.49B | ---- | ---- | 4.28%4.43B | 9.65%4.13B |
| Selling and administrative expenses | ---- | ---- | ---- | 8.73%1.4B | 1.78%1.26B | -1.89%1.24B | ---- | ---- | -1.61%1.28B | 1.23%1.24B |
| -General and administrative expense | ---- | ---- | ---- | 8.73%1.4B | 1.78%1.26B | -1.89%1.24B | ---- | ---- | -1.61%1.28B | 1.23%1.24B |
| Depreciation and amortization | ---- | ---- | ---- | 8.01%310M | 5.42%292M | 5.88%288M | ---- | ---- | 3.99%287M | 1.84%277M |
| -Depreciation | ---- | ---- | ---- | 8.01%310M | 5.42%292M | 5.88%288M | ---- | ---- | 3.99%287M | 1.84%277M |
| Other operating expenses | ---- | ---- | ---- | 13.76%3.58B | 0.56%3.44B | 1.23%3.36B | ---- | ---- | 9.38%3.15B | 16.93%3.42B |
| Operating profit | -6.52%7.36B | -19.06%7.87B | 314.17%1.32B | -29.86%2.42B | -30.95%2.43B | -49.36%1.71B | -22.06%9.72B | -126.04%-614M | -21.52%3.45B | -4.74%3.52B |
| Net non-operating interest income (expenses) | -0.31%-325M | 6.90%-324M | 8.43%-76M | 16.13%-78M | 2.27%-86M | 0.00%-84M | -3.26%-348M | -9.21%-83M | -9.41%-93M | 0.00%-88M |
| Non-operating interest income | 76.47%30M | 13.33%17M | 20.00%6M | 250.00%7M | -66.67%2M | 0.00%2M | 7.14%15M | -16.67%5M | -60.00%2M | 200.00%6M |
| Non-operating interest expense | 4.11%355M | -6.06%341M | -6.82%82M | -10.53%85M | -6.38%88M | 0.00%86M | 3.42%363M | 7.32%88M | 5.56%95M | 4.44%94M |
| Net investment income | 2.07%148M | 0.00%145M | -25.00%6M | 146.21%61M | 58.82%-14M | -69.64%92M | 14.17%145M | 60.00%8M | -488.24%-132M | -466.67%-34M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -90.79%7M | 744.44%76M | 5M | 70M | 0 | -75.00%1M | 145.00%9M | 0 | 0 | 5M |
| Income from associates and other participating interests | 0 | 0 | 0 | -48.82%65M | 0 | -41.03%23M | -7.14%26M | |||
| Special income (charges) | -218.03%-194M | -106.76%-61M | -136.53%-301M | 439.34%329M | -82.61%4M | -1,450.00%-93M | 3,440.74%902M | 13,833.33%824M | 6,200.00%61M | 187.50%23M |
| Less:Restructuring and mergern&acquisition | -3.70%-56M | ---54M | ---38M | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Less:Other special charges | 450.00%66M | 100.86%12M | 125.82%331M | -439.34%-329M | 82.61%-4M | 151.85%14M | -5,672.00%-1.39B | -32,150.00%-1.28B | -6,200.00%-61M | -187.50%-23M |
| Less:Write off | 78.64%184M | -79.02%103M | -98.25%8M | --0 | --16M | 139.39%79M | 477.65%491M | 438.82%458M | --0 | --0 |
| Other non-operating income (expenses) | -37.15%614M | 46.26%977M | 142.60%541M | -16.67%85M | 35.37%199M | -22.45%152M | -6.96%668M | 328.85%223M | -57.68%102M | -65.33%147M |
| Income before tax | -12.36%7.61B | -22.25%8.68B | 313.30%1.49B | -15.45%2.89B | -29.53%2.53B | -53.37%1.77B | -14.52%11.17B | -84.58%361M | -26.21%3.41B | -11.43%3.6B |
| Income tax | -4.79%3.26B | -17.66%3.43B | -1.53%578M | 9.66%1.12B | -24.66%953M | -39.95%771M | 6.66%4.16B | -30.12%587M | -20.60%1.03B | 20.71%1.27B |
| Net income | -17.28%4.35B | -24.99%5.26B | 504.42%914M | -26.26%1.76B | -32.18%1.58B | -60.25%999M | -23.53%7.01B | -115.07%-226M | -28.35%2.39B | -22.61%2.33B |
| Net income continuous operations | -17.29%4.35B | -24.98%5.26B | 504.42%914M | -26.23%1.76B | -32.18%1.58B | -60.22%1B | -23.54%7.01B | -115.06%-226M | -28.38%2.39B | -22.61%2.33B |
| Noncontrolling interests | -68.78%64M | -35.74%205M | 66.67%5M | -38.46%80M | -40.40%59M | -29.89%61M | 25.59%319M | -91.67%3M | 18.18%130M | 52.31%99M |
| Net income attributable to the company | -15.17%4.28B | -24.48%5.05B | 496.94%909M | -25.56%1.68B | -31.81%1.52B | -61.34%938M | -24.94%6.69B | -115.65%-229M | -29.99%2.26B | -24.26%2.23B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -15.17%4.28B | -24.48%5.05B | 496.94%909M | -25.56%1.68B | -31.81%1.52B | -61.34%938M | -24.94%6.69B | -115.65%-229M | -29.99%2.26B | -24.26%2.23B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -15.17%148.18 | -22.32%174.67 | 548.64%31.45 | -23.19%58.14 | -29.67%52.62 | -60.10%32.46 | -24.71%224.85 | -114.29%-7.01 | -29.96%75.69 | -24.27%74.82 |
| Diluted earnings per share | -15.17%148.18 | -22.32%174.67 | 497.15%31.4453 | -23.19%58.1164 | -29.67%52.62 | -60.10%32.46 | -24.71%224.85 | -116.14%-7.9178 | -29.98%75.6673 | -24.27%74.82 |
| Dividend per share | 12.50%45 | 14.29%40 | 25.00%25 | 0 | 0.00%15 | 0 | 0.00%35 | 0.00%20 | 0 | 0.00%15 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |